Showing results 1 to 50 from more than 200,000 results:

Imatinib Mesylate: Top KOLs in the world



World Rank Name Topic PersonRank Score help
#1
Renaud ********** (Reveal full name)
Novartis, Switzerland | Novartis Pharma, Switzerland | Novar
Also Ranks for:
Imatinib Mesylate
Cytogenetic Response
Checkpoint Inhibitors
Clonal Evolution
accelerated phase
Imatinib MesylateReveal score
#2
Sasa ************ (Reveal full name)
Blueprint Medicines Corporation, Zug, Switzerland | Blueprin
Also Ranks for:
Imatinib Mesylate
Advanced Solid Tumors
Patients Gists
Consultancy Membership
gastrointestinal stromal
Imatinib MesylateReveal score
#3
Burton ***** ********* (Reveal full name)
Hoag Family Cancer Institute, Newport Beach, CA; | Universit
Also Ranks for:
Imatinib Mesylate
Gastrointestinal Stromal Tumors
Radiation Therapy
Breast Cancer
surgical clips
Imatinib MesylateReveal score
#4
George ****** ******* (Reveal full name)
Department of Medical Oncology, Dana-Farber Cancer Institute
Also Ranks for:
Gastrointestinal Stromal
Imatinib Mesylate
Epoetin Alfa
Solid Tumors
soft tissue
Imatinib MesylateReveal score
#5
Charles ***** ****** (Reveal full name)
SWOG Group Chair's Office, Knight Cancer Institute, Oregon H
Also Ranks for:
Colorectal Cancer
Imatinib Mesylate
Gastrointestinal Stromal
Phase Iii
southwest oncology
Imatinib MesylateReveal score
#6
Margaret *** ****** (Reveal full name)
Fox Chase Cancer Center, Philadelphia, PA | Department of He
Also Ranks for:
Gastrointestinal Stromal
Imatinib Mesylate
Advanced Gist
Advisory Consultancy
grant funding institution
Imatinib MesylateReveal score
#7
Brian * ****** (Reveal full name)
Division of Oncologic Sciences, Department of Medicine, Oreg
Also Ranks for:
Board Directors
Tyrosine Phosphorylation
Consultancy Funding
Advisory Committees
chronic myeloid leukemia
Imatinib MesylateReveal score
#8
Elisabeth ********** (Reveal full name)
Novartis Institutes for BioMedical Research, Novartis Campus
Also Ranks for:
Growth Factor
Tyrosine Kinase
Imatinib Mesylate
Tumor Cells
oncogene proteins
Imatinib MesylateReveal score
#9
Moshe ****** (Reveal full name)
Division of Hematology and Oncology, University of Michigan
Also Ranks for:
Chronic Myelogenous Leukemia
Consultancy Funding
Speakers Bureau
Imatinib Mesylate
philadelphia chromosome
Imatinib MesylateReveal score
#10
Junia * **** (Reveal full name)
Faculty of Health and Medical Sciences, University of Adelai
Also Ranks for:
Chronic Myeloid Leukemia
Bcr Abl
Imatinib Mesylate
Cml Patients
cell lines
Imatinib MesylateReveal score
#11
Charles * ******* (Reveal full name)
Human Oncology and Pathogenesis Program, Memorial Sloan Kett
Also Ranks for:
Androgen Receptor
Chronic Myeloid Leukemia
Bcr Abl
Imatinib Mesylate
prostate cancer
Imatinib MesylateReveal score
#12
Michael ******* ******** (Reveal full name)
Portland VA Health Care System and OHSU Knight Cancer Instit
Also Ranks for:
Gastrointestinal Stromal
Tyrosine Kinase
Kit Mutations
Imatinib Mesylate
fanconi anemia
Imatinib MesylateReveal score
#13
Christopher * ******* (Reveal full name)
Knight Cancer Institute and Department of Pathology, OHSU, P
Also Ranks for:
Gastrointestinal Stromal Tumors
Liver Transplantation
Kit Mutations
Imatinib Mesylate
breast carcinoma
Imatinib MesylateReveal score
#14
Peter * ******* (Reveal full name)
Turku University Central Hospital, Department of Surgery, Ki
Also Ranks for:
Tumour Markers
Carcinoembryonic Antigen
Imatinib Mesylate
Gastrointestinal Stromal
pancreatic cancer
Imatinib MesylateReveal score
#15
Hagop *********** ********** (Reveal full name)
Department of Leukemia, The University of Texas MD Anderson
Also Ranks for:
Board Directors
Advisory Committees
Honoraria Membership
Consultancy Funding
Imatinib MesylateReveal score
#16
Bin **** (Reveal full name)
Clinical Pharmacology, GlaxoSmithKline, Research Triangle Pa
Also Ranks for:
Cardiac Repolarization
Renal Impairment
Chronic Myeloid Leukemia
Rosuvastatin Exposure
imatinib mesylate
Imatinib MesylateReveal score
#17
Debra * ***** (Reveal full name)
Novartis Pharmaceuticals, Florham Park, NJ; | Department of
Also Ranks for:
Philadelphia Chromosome
Chronic Myeloid Leukemia
Specific Inhibitor
Normal Volunteers
imatinib mesylate
Imatinib MesylateReveal score
#18
Sandra * ********* (Reveal full name)
Novartis Oncology, Novartis Pharma AG, Basel, Switzerland, a
Also Ranks for:
Patients Gists
Gastrointestinal Stromal
Tyrosine Kinase Inhibitor
Kit Pdgfra
imatinib mesylate
Imatinib MesylateReveal score
#19
Andreas ******** (Reveal full name)
Klinik Für Innere Medizin II, Abteilung Hämatologie Und Inte
Also Ranks for:
Honoraria Funding
Chronic Myeloid Leukemia
Novartis Consultancy
Speakers Bureau
board directors
Imatinib MesylateReveal score
#20
Nicholas * ***** (Reveal full name)
Kinetix Pharm., Inc., Medford, MA 02155, USA | 3465 North Pi
Also Ranks for:
Protein Kinase
Growth Factor
Adenylate Cyclase
Tumor Cells
guanine nucleotides
Imatinib MesylateReveal score
#21
John * ******* (Reveal full name)
Centre for Haematology, Imperial College London at Hammersmi
Also Ranks for:
Chronic Myeloid Leukemia
Bone Marrow
Bcr Abl
Cml Patients
stem cell
Imatinib MesylateReveal score
#22
Michele ********* (Reveal full name)
IRCCS Azienda Ospedaliero –Universitaria di Bologna, Bologna
Also Ranks for:
Chronic Myeloid Leukemia
Speakers Bureau
Consultancy Honoraria
Funding Novartis
multiple myeloma
Imatinib MesylateReveal score
#23
François ******* (Reveal full name)
Inserm CIC 1402 CHU de Poitiers, Poitiers, France | INSERM C
Also Ranks for:
Chronic Myeloid Leukemia
Speakers Bureau
Honoraria Funding
Ariad Novartis
Imatinib MesylateReveal score
#24
John * **** (Reveal full name)
Novartis Pharma AG, CH-4002, Basel, Switzerland | Centro del
Also Ranks for:
Chelation Therapy
Dsx Dfo
Chronic Myeloid Leukemia
Serum Ferritin
advanced fibrosis
Imatinib MesylateReveal score
#25
Michael ****** ******** ********* (Reveal full name)
Huntsman Cancer Institute, The University of Utah, Salt Lake
Also Ranks for:
Consultancy Funding
Chronic Myeloid Leukemia
Board Directors
Advisory Committees
speakers bureau
Imatinib MesylateReveal score
#26
Sayuri ********* (Reveal full name)
From the Division of Hematology and Medical Oncology, Oregon
Also Ranks for:
Tyrosine Kinase
Antileukemic Agents
Chronic Myeloid Leukemia
Cgp 57148
specific inhibitor
Imatinib MesylateReveal score
#27
Jorge ******* ****** (Reveal full name)
Georgia Cancer Center, Augusta, United States of America | D
Also Ranks for:
Consultancy Funding
Chronic Myeloid Leukemia
Board Directors
Advisory Committees
honoraria membership
Imatinib MesylateReveal score
#28
Timothy ***** ****** (Reveal full name)
Faculty of Health and Medical Sciences, University of Adelai
Also Ranks for:
Honoraria Funding
Chronic Phase
Speakers Bureau
Novartis Consultancy
board directors
Imatinib MesylateReveal score
#29
Richard * ****** (Reveal full name)
University of Chicago, Chicago, Illinois, USA | University o
Also Ranks for:
Myeloid Leukemia
Honoraria Funding
Chronic Phase
Speakers Bureau
novartis consultancy
Imatinib MesylateReveal score
#30
Carlo * ******************** (Reveal full name)
Department of Medicine and Surgery, University of Milano‐Bic
Also Ranks for:
Honoraria Funding
Pfizer Consultancy
Chronic Myeloid Leukemia
Speakers Bureau
ariad novartis
Imatinib MesylateReveal score
#31
Insa ******** (Reveal full name)
Novartis Pharmaceuticals, Basel, Switzerland | Novartis Phar
Also Ranks for:
Honoraria Funding
Chronic Phase
Patients Imatinib
Novartis Consultancy
cytogenetic response
Imatinib MesylateReveal score
#32
Heikki * ******* (Reveal full name)
Orion Corporation, Espoo, Finland; | Comprehensive Cancer Ce
Also Ranks for:
Adjuvant Imatinib
Gastrointestinal Stromal
Merkel Cell
Hodgkin Lymphoma
breast cancer
Imatinib MesylateReveal score
#33
Giuseppe ****** ****** (Reveal full name)
Department of Clinical and Biological Sciences, University o
Also Ranks for:
Chronic Myeloid Leukemia
Consultancy Honoraria
Speakers Bureau
Novartis Funding
bcr abl
Imatinib MesylateReveal score
#34
Jonathan ****** ******** (Reveal full name)
Department of Pathology, Brigham and Women's Hospital, Harva
Also Ranks for:
Gastrointestinal Stromal Tumors
Breast Cancer
Human Pair
Kit Mutations
situ hybridization
Imatinib MesylateReveal score
#35
Christopher * * ********* (Reveal full name)
Department of Pathology, Brigham and Women's Hospital, Bosto
Also Ranks for:
Situ Hybridization
Fibrous Histiocytoma
Gastrointestinal Stromal Tumors
Spindle Cell
soft tissue
Imatinib MesylateReveal score
#36
Oliver ******* ******* (Reveal full name)
Division of Cancer and Genetics, School of Medicine, Cardiff
Also Ranks for:
Honoraria Funding
Myelodysplastic Syndromes
Bcr Abl
Board Directors
novartis consultancy
Imatinib MesylateReveal score
#37
Josy * ******** (Reveal full name)
University of Bordeaux, ; Bordeaux, France | Institut Bergon
Also Ranks for:
Bone Marrow
Multiple Myeloma
Acute Myeloid Leukemia
Complete Remission
stem cell
Imatinib MesylateReveal score
#38
François ****** ***** (Reveal full name)
Groupe Fi-LMC, Centre Léon Bérard, Lyon, France; Hematology
Also Ranks for:
Speakers Bureau
Chronic Myeloid Leukemia
Honoraria Funding
Novartis Consultancy
cml patients
Imatinib MesylateReveal score
#39
Susan **** ** ***** (Reveal full name)
University of California Irvine, Orange, California, United
Also Ranks for:
Consultancy Funding
Chronic Lymphocytic Leukemia
Board Directors
Inotuzumab Ozogamicin
advisory committees
Imatinib MesylateReveal score
#40
David * ******* (Reveal full name)
Lustgarten Foundation Pancreatic Cancer Research Laboratory,
Also Ranks for:
Mouse Models
Stromal Cells
Ductal Adenocarcinoma
Oncogenic Kras
pancreatic cancer
Imatinib MesylateReveal score
#41
Thomas ******* (Reveal full name)
Brandenburgische Technische Universität Cottbus-Senftenberg,
Also Ranks for:
Insertion Site
Abusive Supervision
Circular Causality
12 Months
conductive adhesives
Imatinib MesylateReveal score
#42
Dietger * ************* (Reveal full name)
University of Leipzig, Leipzig, Germany. | University Clinic
Also Ranks for:
Stem Cell
Marrow Transplantation
Acute Myeloid Leukemia
Multiple Myeloma
honoraria funding
Imatinib MesylateReveal score
#43
Alois ******** (Reveal full name)
University Hospital Basel, Switzerland (A.G.)
Also Ranks for:
Patients Imatinib
Ebmt Risk Score
Chronic Myeloid Leukemia
Cytogenetic Responses
blast crisis
Imatinib MesylateReveal score
#44
Alois * ******** (Reveal full name)
Hematology, Medical Faculty, University of Basel, Basel, Swi
Also Ranks for:
Stem Cell
Bone Marrow
Host Disease
Autologous Transplantation
chronic myeloid leukemia
Imatinib MesylateReveal score
#45
Samuel ****** (Reveal full name)
Department of Surgery, Weill Cornell Medical College, 10065,
Also Ranks for:
Soft Tissue
Gastrointestinal Stromal
Radiation Therapy
Dedifferentiated Liposarcoma
synovial sarcoma
Imatinib MesylateReveal score
#46
Stephen * ******** (Reveal full name)
Laboratory of Genomic Diversity, Center for Computer Technol
Also Ranks for:
Human Chromosome
Domestic Cats
Genetic Variation
Chronic Phase
african americans
Imatinib MesylateReveal score
#47
Philippe * ********* (Reveal full name)
Hospital Mignot University de Versailles Saint-Quentin-en-Yv
Also Ranks for:
Speakers Bureau
Honoraria Funding
Chronic Myeloid Leukemia
Novartis Consultancy
board directors
Imatinib MesylateReveal score
#48
James * ******* (Reveal full name)
Department of Medicine, Harvard Medical School, Boston, MA,
Also Ranks for:
Bcr Abl
Tyrosine Kinase
Myeloid Leukemia
Maintenance Therapy
stimulating factor
Imatinib MesylateReveal score
#49
Bengt ********* (Reveal full name)
Division of Hematology, Department of Medical Science, Uppsa
Also Ranks for:
Chronic Myeloid Leukemia
Multiple Myeloma
Bone Marrow
Honoraria Funding
novartis consultancy
Imatinib MesylateReveal score
#50
Thomas ***** ******* (Reveal full name)
Department of Nuclear Medicine, Faculty of Medicine and Univ
Also Ranks for:
Tyrosine Kinase
Acute Myeloid Leukemia
Bortezomib Consolidation
Heart Failure
late ina
Imatinib MesylateReveal score